Zymeworks Inc. Common Stock (ZYME) stock news · rev $106.0M
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
This ZYME news page leads with what Zymeworks Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for ZYME yet. We will not pad this page with generic market recap.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ZYME stock page; for the tape open the quote page.
ZYME stock news FAQ
What are ZYME's latest revenue and net income?
Latest cached Zymeworks Inc. Common Stock (ZYME) revenue for Dec 31, 2025 was $106.0M. Net income was -$81.1M. Statements: https://lician.com/financials/zyme
How did ZYME revenue change from the prior cached period?
Cached Zymeworks Inc. Common Stock (ZYME) revenue was up 38.9% from $76.3M (Dec 31, 2024) to $106.0M (Dec 31, 2025). Statements: https://lician.com/financials/zyme
What is ZYME's market cap?
Zymeworks Inc. Common Stock (ZYME) market cap is $1.68B on the latest cached fundamentals snapshot.
What kind of company is ZYME?
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Where is ZYME stock news listed?
Cached stock news for Zymeworks Inc. Common Stock (ZYME) is listed at https://lician.com/news/zyme. Filings: https://lician.com/sec/zyme
Not investment advice.